BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2008
View Archived Issues
Nanoscalic silver less toxic than silver sulfadiazine in treating skin infections
Read More
Novel agents for cardiovascular disorders reported in recent patents
Read More
Sanofi-aventis issues 2007 overview
Read More
Recent Kyorin patent describes new treatment option for transplant rejection
Read More
New antipsychotic and anxiolytic agents described in recent patent literature
Read More
Targeting midkine useful in multiple sclerosis model
Read More
NSC-668814 effective against cisplatin-resistant ovarian cancer in vitro
Read More
CHP-HER2 vaccine elicits HER2-specific immune responses in advanced cancer
Read More
Urigen reports phase II study results with URG-101 in painful bladder syndrome
Read More
In vivo results demonstrate good safety profile for Upstream's leishmaniasis drug candidates
Read More
FDA grants approval to Zymenex's IND application for phase II clinical trial of Metazym
Read More
DSMB recommends continuation of Sangart's two phase III clinical trials of Hemospan
Read More
Oxigene plans to file an IND for Zybrestat based on positive results in primates
Read More
Creagene reports positive results from preclinical toxicity tests for CreaVax-HCC injection
Read More
Horizontal gene transfer makes it possible to produce a novel class of antibiotics
Read More
FDA issues nonapprovable letter for Luitpold's NDA for Injectafer in iron deficiency anemia
Read More
AstraZeneca completes enrollment in ZODIAC and ZEAL phase III studies of Zactima
Read More
ArQule starts enrollment in phase I/II ARQ-197 non-small cell lung cancer trial
Read More
Raven to advance development of its new IND candidate RAV-18
Read More
Vertex and Tibotec commence phase III ADVANCE study with telaprevir in HCV
Read More
BioInvent enters agreement with Bayer HealthCare for human monoclonal antibodies
Read More
Recordati completes mutual recognition process in Europe for lercanidipine/enalapril
Read More
AVI BioPharma acquires Ercole Biotech
Read More
Unigene reports results from phase I/II clinical study of oral calcitonin
Read More
Celsion initiates screening of patients in phase II study of ThermoDox in HCC
Read More